Cargando…

Theory, Targets and Therapy in Rheumatic Diseases

Detalles Bibliográficos
Autor principal:	Bosnić, Dubravka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Communications and Publications Division (CPD) of the IFCC 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938685/ https://www.ncbi.nlm.nih.gov/pubmed/29760638

Ejemplares similares

The potential role of 'non-rheumatic’ therapies in rheumatic disease
por: Massarotti, Elena M, et al.
Publicado: (2013)

The Theory of Anaphylaxis and the Therapeutic Possibilities in Rheumatism
por: Levinthal, Walter M.
Publicado: (1945)

Eosinophilia-myalgia syndrome induced by excessive L-tryptophan intake from cashew nuts
por: Barešić, Marko, et al.
Publicado: (2014)

Targeting Syk in Autoimmune Rheumatic Diseases
por: Deng, Guo-Min, et al.
Publicado: (2016)

Rheumatic diseases, rheumatism and arthritis
por: Brugsch, Heinrich Georg, 1903-
Publicado: (1957)

A Theory That May Account for the Bacteriology of Rheumatism
por: Houston, Thomas
Publicado: (1934)

Improvement of overlapping hidradenitis suppurativa and ankylosing spondylitis after the introduction of adalimumab
por: Bosnić, Dubravka, et al.
Publicado: (2016)

Peptide-Based Vaccination Therapy for Rheumatic Diseases
por: Wang, Bin, et al.
Publicado: (2020)

Therapeutics for rheumatic fever and rheumatic heart disease
por: Ralph, Anna P, et al.
Publicado: (2022)

Iatrogenic antibody deficiency from B-cell targeted therapies in autoimmune rheumatic diseases
por: Wijetilleka, Sonali, et al.
Publicado: (2019)

Gene therapy of the rheumatic diseases: 1998 to 2008
por: Evans, Christopher H, et al.
Publicado: (2009)

A systematic review of psychosocial therapies for children with rheumatic diseases
por: Cohen, Ezra M., et al.
Publicado: (2017)

Rheumatic Diseases in China
por: Zeng, Qing Yu, et al.
Publicado: (2008)

Clinical outcomes of patients with COVID-19 and inflammatory rheumatic diseases receiving biological/targeted therapy
por: Pehlivan, Özlem, et al.
Publicado: (2022)

Editorial: Recent Advances in Potential Biomarkers for Rheumatic Diseases and in Cell-Based Therapies in the Management of Inflammatory Rheumatic Diseases
por: Saas, Philippe, et al.
Publicado: (2022)

Garden of therapeutic delights: new targets in rheumatic diseases
por: Waldburger, Jean M, et al.
Publicado: (2009)

The Rheumatic Diseases
Publicado: (1950)

The Rheumatic Diseases
Publicado: (1905)

The Rheumatic Diseases
Publicado: (1945)

Special Issue “Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 2022”
por: Ruaro, Barbara, et al.
Publicado: (2023)

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases
por: Cantatore, Francesco Paolo, et al.
Publicado: (2017)

Molecular Mechanism of Rheumatic Diseases and Efficacy of Current Therapies
por: Umar, Sadiq, et al.
Publicado: (2017)

Psychogenic Rheumatism: Its Differentiation from True Rheumatic Disease
por: Hench, Philip S.
Publicado: (1949)

Acute rheumatic fever and rheumatic heart disease in Victoria, 2006–18
por: Oliver, Jane, et al.
Publicado: (2021)

Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
por: Ceribelli, Angela, et al.
Publicado: (2020)

Twins with Rheumatic Diseases
por: Dixon, A. St. J.
Publicado: (1969)

Research on Rheumatic Diseases
por: Kersley, G. D.
Publicado: (1961)

Rheumatic fever and rheumatic heart disease in Bangladesh: A review
por: Islam, A.K.M. Monwarul, et al.
Publicado: (2016)

Rheumatic Heart Disease
por: Basu, U. P.
Publicado: (1941)

Rheumatic diseases in Africa
por: Adelowo, Olufemi, et al.
Publicado: (2021)

Glycobiology of rheumatic diseases
por: Kissel, Theresa, et al.
Publicado: (2022)

Rheumatic fever & rheumatic heart disease: The last 50 years
por: Kumar, R. Krishna, et al.
Publicado: (2013)

B Cells as a Therapeutic Target in Paediatric Rheumatic Disease
por: Wilkinson, Meredyth G. Ll, et al.
Publicado: (2019)

Flavonoids: Nutraceuticals for Rheumatic Diseases via Targeting of Inflammasome Activation
por: Yi, Young-Su
Publicado: (2021)

Editorial: Frontiers in Autoimmune Disease: Rheumatic Fever and Rheumatic Heart Disease
por: Guilherme, Luiza, et al.
Publicado: (2015)

Interleukin 17 and Treg – a common pathomechanism and a new target of therapy in rheumatic diseases and depression
por: Gałecki, Piotr, et al.
Publicado: (2018)

Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies
por: Sanchez-Piedra, Carlos, et al.
Publicado: (2020)

Global research priorities in rheumatic fever and rheumatic heart disease
por: Carapetis, Jonathan R, et al.
Publicado: (2011)

The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease
por: Seckeler, Michael D, et al.
Publicado: (2011)

Rheumatic Fever and Rheumatic Heart Disease a Historical Perspective
por: Hajar, Rachel
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fq2co4ru5vu85c23k94ue0easo